Kwality Pharmaceuticals Share Price

CMP as on23-May-22 14:53

₹ 397.25
18.9 5%

Open

₹ 397.00

Turnover (lac)

₹ 4

Prev. Close

₹ 378.35

Day's Vol (shares)

₹ 2,200

Day's Range

₹ 393.95
₹ 397.25

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 02-Nov-2021 - -
Inter alia, to consider and approve the Migration of the Company from BSE SME Platform to Main Board of BSE Limited subject to approval of shareholders and other matters related or incidental thereto. This is to inform that the Board of Directors of the Company have, at their meeting held on Wednesday, 10th November, 2021 inter alia, considered and approved the following key agendas: 1. Approved the Migration of the Company from SME Platform of BSE Limited to main Board of BSE Limited in terms of SEBI (ICDR) Regulations, 2018 subject to necessary approvals including shareholders approval. 2. Approved the Notice of Postal Ballot for migration of Companys present listing of Equity Shares from SME Platform of BSE Limited to the Main Board of BSE Limited . 3. The Board has fixed Friday, 12th November, 2021 as cut -off date for determining the eligibility of the members to receive Postal Ballot Notice and to excise voting rights by remote e-voting. 4. Appointed CS Rishi Mittal, Practicing Company Secretary from Amritsar, as a Scrutinizer to conduct the Postal Ballot process. (As per BSE Announcement 10/11/2021)
Board Meeting - 12-Oct-2021 - -
Half Yearly Results Kwality Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/10/2021 ,inter alia, to consider and approve the Standalone and Consolidated Unaudited Financial Results of the Company for the half year ended on 30th September, 2021 We are submitting herewith the standalone and consolidated un-audited financial results under Regulation 33 of the Securities and Exchange board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the half year ended as on 30.09.2021 along with the limited review reports thereon. (As Per BSE Announcement dated on 22.10.2021)
Board Meeting - 06-Sep-2021 - -
This is to inform you under regulation 30 and any other regulations of SEBI (LODR) Regulations, 2015 that meeting of the Board of Directors of the company was held on 6th September, 2021 and the said meeting commenced at 5:00 P.M. and concluded at 07:30 P.M. at the registered office of the Company. The following matters were decided by the board: 1. The Board of directors of the company have considered and approved the Report of Board of Directors under Section 134 of the Companies Act, 2013. 2. The Board of directors of the company have considered and approved the Notice of 38th Annual General Meeting of the Company. 3. Date, Time and Place of the 38th Annual General Meeting has been fixed. 4. Dates of Book Closure for the purpose of 38th Annual General Meeting has been fixed and approved by the Board. In reference to the aforesaid subject, a meeting of the Board of Directors of the Company is held on 06.09.2021, which inter alia has approved the followings:- 1. Convening of 38th Annual General Meeting of the Company at registered office of the Company at VILLAGE NAGKALAN, MAJITHA ROAD, AMRITSAR, PUNJAB-143601 AT 11:30 A.M. on Thursday 30th September, 2021. 2. Register of Members and Share Transfer Books of the Company will remain closed from Thursday, 23rd September, 2021 to Thursday, 30th September, 2021 (both days inclusive) for the purpose of 38th Annual General Meeting of the company.
Board Meeting - 22-Jun-2021 - -
Kwality Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2021 ,inter alia, to consider and approve the standalone & consolidated audited financial results for the half year and financial year ended on 31st March, 2021. We wish to inform you that at the Board Meeting held today i.e. on Wednesday, June 30, 2021, the Board of Directors of the Company have inter alia Considered and approved the Audited Standalone and Consolidated Financial Results for the Half Year & Year Ended 31st March, 2021 which are enclosed herewith. (AS Per BSE Announcement Dated on 30.06.2021)
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity